Connect with us

Life Sciences

Maximizing Laboratory Efficiency and Output with Microfluidics-Based PCR

In this eBook, sponsored by Standard BioTools, we examine challenges and solutions in PCR and real-time PCR assay design and highlight the expanding use…

Published

on

This article was originally published by GEN Genetic Engineering and Biotechnology News

View eBook
 

Standard Bio ebook cover

Modifications and adaptations continue to improve how we use PCR, spurring a new level of creativity in genomics hypotheses and enabling a broad versatility in applications. PCR has the speed, sensitivity and reliability to assume an ever-expanding role in a wide range of basic, translational and clinical research approaches. Employing tools like microfluidics has further simplified and accelerated genomic analysis using PCR, with the ability to run thousands of reactions in one chip.

For biobanking endeavors, this empowers a rapid and confident test for sample identification, quality control and assessment. It is a universally recognized priority to ensure accurate sample tracking and quality acquisition, typically done using DNA fingerprinting. This methodology can extend from high-throughput genomics centers to biorepositories or centralized cell line banks.

In pharmacogenomics (PGx), the study of how genes affect individual response to drugs, tools capable of quickly and easily investigating the relationship between a specific gene profile and a novel drug can improve efficacy and shorten the time to research insights. Advances to real-time PCR using microfluidics technology facilitate PGx studies with a single high-throughput workflow that consolidates multiple assays into one experiment, without the  need for multiplexing.

Tumor gene expression has proven to be an effective measure of immune response in cancer progression and therapeutic response research. As emerging therapies reveal new biomarkers and expand the need for samples, the costs and labor required to complete this important work increase, necessitating sensitive and cost-effective toolsets for identifying gene expression signatures from immune and cancer cells.

In this eBook, we examine challenges and solutions in PCR and real-time PCR assay design and highlight the expanding use of microfluidics-based PCR.

 

 Sponsored by:

Standard Biotools logo

The post Maximizing Laboratory Efficiency and Output with Microfluidics-Based PCR appeared first on GEN – Genetic Engineering and Biotechnology News.


Markets

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending